Correction: Defining the Phenotype and Assessing Severity in Phosphoglucomutase-1 Deficiency (The Journal of Pediatrics (2016) 175 (130–136.e8) (S0022347616300695) (10.1016/j.jpeds.2016.04.021));Defining the Phenotype and Assessing Severity in Phosphoglucomutase-1 Deficiency

Journal of Pediatrics

Volumn 175, Issue , 2016, Pages 130-136.e8

  Wong, Sunnie Yan Wai ^a   Gadomski, Therese ^a   Kozicz, Tamas ^a   Morava, Eva ^a,d   Beamer, Lesa J ^b   Honzik, Tomas ^c   Mohamed, Miski ^d   Wortmann, Saskia B ^e   Brocke Holmefjord, Katja S ^f   Mork, Marit ^f   Bowling, Francis ^g   Sykut Cegielska, Jolanta ^h   Koch, Dieter ⁱ   Ackermann, Amanda ^j   Stanley, Charles A ^j   Rymen, Daisy ^k   Zeharia, Avraham ^l   Al Sayed, Moeen ^m   Marquardt, Thomas ⁿ   Jaeken, Jaak ^k   Lefeber, Dirk ^d   Conrad, Donald F ^o   more..

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c CHARLES UNIVERSITY   (Czech Republic)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e PARACELSUS MEDICAL UNIVERSITY   (Austria)

^f STAVANGER UNIVERSITY HOSPITAL   (Norway)

^g MATER CHILDREN S HOSPITAL   (Australia)

^h INSTITUTE OF MOTHER AND CHILD   (Poland)

ⁱ Bergisch Gladbacher Koln   (Germany)

^j CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^k UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^l TEL AVIV UNIVERSITY   (Israel)

^m KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

ⁿ UNIVERSITY OF MÜNSTER   (Germany)

^o WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

bifid uvula; cleft palate; coagulopathy; congenital disorder of glycosylation; congenital malformation; dilated cardiomyopathy; hepatopathy; hormonal deficiency; hypoglycemia; myopathy; small stature

Indexed keywords

PHOSPHOGLUCOMUTASE; GENETIC MARKER; PGM1 PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONGENITAL DISORDER OF GLYCOSYLATION; CONGENITAL MALFORMATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DISEASE SEVERITY ASSESSMENT; ENZYME ACTIVITY; ENZYME DEFICIENCY; FEMALE; GENOTYPE; GROWTH; HEART DISEASE; HORMONE DEFICIENCY; HUMAN; MALE; MYOPATHY; PHENOTYPE; PHOSPHOGLUCOMUTASE 1 DEFICIENCY; PRESCHOOL CHILD; PRIORITY JOURNAL; RATING SCALE; SCHOOL CHILD; SCORING SYSTEM; TULANE PGM1 CDG RATING SCALE; YOUNG ADULT; ALGORITHM; DEFICIENCY; ENZYMOLOGY; GENETIC MARKER; GENETICS; GLYCOGEN STORAGE DISEASE; MUTATION; PHYSICAL EXAMINATION; PRINCIPAL COMPONENT ANALYSIS; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX;

ADOLESCENT; ADULT; ALGORITHMS; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC MARKERS; GENOTYPE; GLYCOGEN STORAGE DISEASE; HUMANS; MALE; MUTATION; PHENOTYPE; PHOSPHOGLUCOMUTASE; PHYSICAL EXAMINATION; PRINCIPAL COMPONENT ANALYSIS; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84971283620     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2016.05.075     Document Type: Erratum

References (37)

1. 1 Theodore, M., Morava, E., Congenital disorders of glycosylation: sweet news. Curr Opin Pediatr 23 (2011), 581–587.
2. 2 Funke, S., Gardeitchik, T., Kouwenberg, D., Mohamed, M., Wortmann, S.B., Korsch, E., et al. Perinatal and early infantile symptoms in congenital disorders of glycosylation. Am J Med Genet A 161A (2013), 578–584.
3. 3 Timal, S., Hoischen, A., Lehle, L., Adamowicz, M., Huijben, K., Sykut-Cegielska, J., et al. Gene identification in the congenital disorders of glycosylation type I by whole-exome sequencing. Hum Mol Genet 21 (2012), 4151–4161.
4. 4 Tegtmeyer, L.C., Rust, S., van Scherpenzeel, M., Ng, B.G., Losfeld, M.-E., Timal, S., et al. Multiple phenotypes in phosphoglucomutase 1 deficiency. N Engl J Med 370 (2014), 533–542.
5. 5 Stojkovic, T., Vissing, J., Petit, F., Piraud, M., Orngreen, M.C., Andersen, G., et al. Muscle glycogenosis due to phosphoglucomutase 1 deficiency. N Engl J Med 361 (2009), 425–427.
6. 6 Morava, E., Galactose supplementation in phosphoglucomutase-1 deficiency; review and outlook for a novel treatable CDG. Mol Genet Metab 112 (2014), 275–279.
7. 7 Thomson, W.H., Maclaurin, J.C., Prineas, J.W., Skeletal muscle glycogenosis: an investigation of two dissimilar cases. J Neurol Neurosurg Psychiatry 26 (1963), 60–68.
8. 8 Pérez, B., Medrano, C., Ecay, M.J., Ruiz-Sala, P., Martínez-Pardo, M., Ugarte, M., et al. A novel congenital disorder of glycosylation type without central nervous system involvement caused by mutations in the phosphoglucomutase 1 gene. J Inherit Metab Dis 36 (2013), 535–542.
9. 9 Beamer, L.J., Mutations in hereditary phosphoglucomutase 1 deficiency map to key regions of enzyme structure and function. J Inherit Metab Dis 38 (2015), 243–256.
10. 10 Lee, Y., Stiers, K.M., Kain, B.N., Beamer, L.J., Compromised catalysis and potential folding defects in in vitro studies of missense mutants associated with hereditary phosphoglucomutase 1 deficiency. J Biol Chem 289 (2014), 32010–32019.
11. 11 Achouitar, S., Mohamed, M., Gardeitchik, T., Wortmann, S.B., Sykut-Cegielska, J., Ensenauer, R., et al. Nijmegen paediatric CDG rating scale: a novel tool to assess disease progression. J Inherit Metab Dis 34 (2011), 923–927.
12. 12 Ondruskova, N., Honzik, T., Vondrackova, A., Tesarova, M., Zeman, J., Hansikova, H., Glycogen storage disease-like phenotype with central nervous system involvement in a PGM1-CDG patient. Neuro Endocrinol Lett 35 (2014), 137–141.
13. 13 Peña, E.A., Slate, E.H., Global Validation of Linear Model Assumptions. J Am Stat Assoc, 101, 2006, 341.
14. 14 Sainani, K.L., Introduction to principal components analysis. PM R 6 (2014), 275–278.
15. 15 Barone, R., Carrozzi, M., Parini, R., Battini, R., Martinelli, D., Elia, M., et al. A nationwide survey of PMM2-CDG in Italy: high frequency of a mild neurological variant associated with the L32R mutation. J Neurol 262 (2015), 154–164.
16. 16 Dercksen, M., Crutchley, A.C., Honey, E.M., Lippert, M.M., Matthijs, G., Mienie, L.J., et al. ALG6-CDG in South Africa: genotype-phenotype description of five novel patients. JIMD Rep 8 (2013), 17–23.
17. 17 Erlandson, A., Bjursell, C., Stibler, H., Kristiansson, B., Wahlström, J., Martinsson, T., Scandinavian CDG-Ia patients: genotype/phenotype correlation and geographic origin of founder mutations. Hum Genet 108 (2001), 359–367.
18. 18 Chanock, S.J., Manolio, T., Boehnke, M., Boerwinkle, E., Hunter, D.J., Thomas, G., et al. Replicating genotype–phenotype associations. Nature 447 (2007), 655–660.
19. 19 Oussoren, E., Keulemans, J., van Diggelen, O.P., Oemardien, L.F., Timmermans, R.G., van der Ploeg, A.T., et al. Residual α-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients. Mol Genet Metab 109 (2013), 377–381.
20. 20 Strauss, K.A., Puffenberger, E.G., Morton, D.H., Maple Syrup Urine Disease. Pagon, R.A., Adam, M.P., Ardinger, H.H., Wallace, S.E., Amemiya, A., Bean, L.J.H., et al. (eds.) GeneReviews(®), 2006, University of Washington, Seattle (WA).
21. 21 Goker-Alpan, O., Hruska, K.S., Orvisky, E., Kishnani, P.S., Stubblefield, B.K., Schiffmann, R., et al. Divergent phenotypes in Gaucher disease implicate the role of modifiers. J Med Genet, 42, 2005, e37.
22. 22 Pindolia, K., Jordan, M., Wolf, B., Analysis of mutations causing biotinidase deficiency. Hum Mutat 31 (2010), 983–991.
23. 23 Hoffmann, L., Haussmann, U., Mueller, M., Spiekerkoetter, U., VLCAD enzyme activity determinations in newborns identified by screening: a valuable tool for risk assessment. J Inherit Metab Dis 35 (2012), 269–277.
24. 24 Maliekal, P., Sokolova, T., Vertommen, D., Veiga-da-Cunha, M., Van Schaftingen, E., Molecular identification of mammalian phosphopentomutase and glucose-1,6-bisphosphate synthase, two members of the alpha-D-phosphohexomutase family. J Biol Chem 282 (2007), 31844–31851.
25. 25 Barembaum, M., Moreno, T.A., LaBonne, C., Sechrist, J., Bronner-Fraser, M., Noelin-1 is a secreted glycoprotein involved in generation of the neural crest. Nat Cell Biol 2 (2000), 219–225.
26. 26 Yu, R.K., Itokazu, Y., Glycolipid and glycoprotein expression during neural development. Adv Neurobiol 9 (2014), 185–222.
27. 27 March, R.E., Putt, W., Hollyoake, M., Ives, J.H., Lovegrove, J.U., Hopkinson, D.A., et al. The classical human phosphoglucomutase (PGM1) isozyme polymorphism is generated by intragenic recombination. Proc Natl Acad Sci U S A 90 (1993), 10730–10733.
28. 28 Vatta, M., Mohapatra, B., Jimenez, S., Sanchez, X., Faulkner, G., Perles, Z., et al. Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. J Am Coll Cardiol 42 (2003), 2014–2027.
29. 29 Arimura, T., Inagaki, N., Hayashi, T., Shichi, D., Sato, A., Hinohara, K., et al. Impaired binding of ZASP/Cypher with phosphoglucomutase 1 is associated with dilated cardiomyopathy. Cardiovasc Res 83 (2009), 80–88.
30. 30 Lane, L., Argoud-Puy, G., Britan, A., Cusin, I., Duek, P.D., Evalet, O., et al. neXtProt: a knowledge platform for human proteins. Nucleic Acids Res 40:Database issue (2012), D76–D83.
31. 31 Stanley, C.A., Rozance, P.J., Thornton, P.S., De Leon, D.D., Harris, D., Haymond, M.W., et al. Re-Evaluating “Transitional Neonatal Hypoglycemia”: Mechanism and Implications for Management. J Pediatr 166 (2015), 1520–1525.e1.
32. 32 Rozance, P.J., Hay, W.W. Jr., Neonatal hypoglycemia—answers, but more questions. J Pediatr 161 (2012), 775–776.
33. 33 Cornblath, M., Reisner, S.H., Blood glucose in the neonate and its clinical significance. N Engl J Med 273 (1965), 378–381.
34. 34 Wolf, Z.T., Brand, H.A., Shaffer, J.R., Leslie, E.J., Arzi, B., Willet, C.E., et al. Genome-wide association studies in dogs and humans identify ADAMTS20 as a risk variant for cleft lip and palate. PLoS Genet, 11, 2015, e1005059.
35. 35 Rahimov, F., Jugessur, A., Murray, J.C., Genetics of nonsyndromic orofacial clefts. Cleft Palate Craniofac J 49 (2012), 73–91.
36. 36 Wehby, G.L., Cassell, C.H., The impact of orofacial clefts on quality of life and healthcare use and costs. Oral Dis, 16, 2010, 310.
37. 1 Lee, Y., Stiers, K.M., Kain, B.N., Beamer, L.J., Compromised catalysis and potential folding defects in in vitro studies of missense mutants associated with hereditary phosphoglucomutase 1 deficiency. J Biol Chem 289 (2014), 32010–32019.